<b>Conclusions</b>: In our study, serum levels of CXCL8 and CXCL10 reflect disease activity and systemic inflammation in SLE, supporting their potential value as biomarkers for monitoring ongoing immune activation. This evidence concerns the gene CXCL8 and systemic lupus erythematosus.